Medicare Enrolled
Dr. Paul Swanson, MD
Hematology & Oncology · Port St Lucie, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Swanson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Swanson? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Swanson
Dr. Paul Swanson is a hematology & oncology in Port St Lucie, FL, with 19 years in practice. Based on federal Medicare data, Dr. Swanson performed 180,706 Medicare services across 5,942 unique beneficiaries.
Between the years covered by Open Payments, Dr. Swanson received a total of $5,445 from 47 pharmaceutical and/or device companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Swanson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in FL$ $5,445 industry payments
Medicare Practice Summary
Medicare Utilization ↗180,706
Medicare services
Top 3% in FL for hematology & oncology
5,942
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,511 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 48,000 | $0 | $2 |
| Iron infusion (Feraheme) | 42,330 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 29,800 | $43 | $91 |
| Filgrastim injection (Nivestym) for white blood cells | 16,380 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 6,360 | $19 | $30 |
| Contrast dye for imaging (iodine-based) | 3,375 | $0 | $1 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 3,270 | $23 | $94 |
| Dexamethasone injection (steroid) | 3,241 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia | 3,220 | $6 | $20 |
| Injection, eflapegrastim-xnst, 0.1 mg | 3,168 | $26 | $65 |
| Complete blood count (CBC) with differential | 2,959 | $8 | $30 |
| Epoetin alfa injection (Retacrit) for anemia | 2,180 | $6 | $24 |
| Office visit, established patient (20-29 min) | 2,084 | $69 | $210 |
| Blood draw (venipuncture) | 2,029 | $8 | $15 |
| Comprehensive metabolic blood panel | 1,939 | $10 | $30 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,310 | $1 | $10 |
| Leuprolide injectable, camcevi, 1 mg | 672 | $68 | $200 |
| Drug injection, under skin or into muscle | 666 | $11 | $40 |
| Administration of chemotherapy into vein, 1 hour or less | 524 | $105 | $330 |
| Anti-nausea injection (ondansetron/Zofran) | 488 | $0 | $2 |
| Lactate dehydrogenase (enzyme) level | 425 | $6 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 362 | $24 | $85 |
| Injection of additional new drug or substance into vein | 346 | $13 | $55 |
| Hospital follow-up visit, moderate complexity | 332 | $66 | $165 |
| Injection, carboplatin, 50 mg | 322 | $2 | $10 |
| Office visit, established patient (30-39 min) | 299 | $99 | $300 |
| Ferritin level test (iron stores) | 284 | $13 | $40 |
| Iron binding capacity test | 243 | $9 | $25 |
| Iron level test | 242 | $6 | $20 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 225 | $1 | $6 |
| PSA test (prostate cancer screening) | 201 | $18 | $75 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 190 | $52 | $150 |
| Infusion, normal saline solution , 1000 cc | 190 | $2 | $10 |
| Injection, diphenhydramine hcl, up to 50 mg | 189 | $1 | $4 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 175 | $59 | $125 |
| Infusion into a vein for hydration, each additional hour | 174 | $11 | $40 |
| Infusion into a vein for hydration, 31-60 minutes | 167 | $26 | $125 |
| Administration of chemotherapy into vein, each additional hour | 166 | $23 | $80 |
| Carcinoembryonic antigen (cea) protein level | 156 | $19 | $55 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 146 | $137 | $438 |
| Injection, magnesium sulfate, per 500 mg | 134 | $1 | $2 |
| Administration of additional new drug or substance into vein, 1 hour or less | 130 | $53 | $165 |
| New patient office visit, complex (60-74 min) | 97 | $174 | $520 |
| Initial hospital admission, high complexity | 93 | $144 | $460 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 92 | $17 | $50 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 90 | $24 | $85 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 89 | $20 | $60 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 89 | $3 | $10 |
| Vitamin B-12 level test | 81 | $15 | $50 |
| Basic metabolic blood panel | 69 | $8 | $25 |
| CT scan of chest, without contrast | 67 | $43 | $366 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 64 | $4 | $12 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 64 | $1 | $4 |
| Prothrombin time test (blood clotting) | 63 | $4 | $15 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 57 | $407 | $681 |
| Folic acid level test | 52 | $14 | $55 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 51 | $1,196 | $5,700 |
| Collection of blood sample from implanted device | 50 | $20 | $50 |
| Ct scan of abdomen and pelvis without contrast | 48 | $83 | $1,075 |
| Magnesium level test | 45 | $7 | $20 |
| Irrigation of implanted venous access drug delivery device | 45 | $19 | $55 |
| Blood creatinine level | 36 | $5 | $15 |
| Urea nitrogen level to assess kidney function, quantitative | 36 | $4 | $7 |
| Administration of additional new drug or substance into vein using push technique | 36 | $46 | $140 |
| Manual urinalysis test with examination using microscope, non-automated | 34 | $4 | $20 |
| Drawing of blood for a medical problem | 30 | $75 | $165 |
| Anticoagulant management of patient taking warfarin | 28 | $8 | $25 |
| Stool analysis for blood, by peroxidase activity | 27 | $4 | $10 |
| Ct scan of chest with contrast | 25 | $58 | $700 |
| Uric acid level test | 20 | $4 | $10 |
| Liver function blood test panel | 18 | $7 | $25 |
| Ct scan of abdomen and pelvis before and after contrast | 17 | $211 | $1,450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
24.1% high complexity
68.6% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,445
Total received (2018-2024)
Avg $778/year across 7 years
Top 47% in FL for hematology & oncology
47
Companies
354
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,433 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$174
2023$232
2022$177
2021$59
2020$526
2019$2,223
2018$2,054
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$750
Amgen Inc.
$703
Novartis Pharmaceuticals Corporation
$465
PFIZER INC.
$382
Merck Sharp & Dohme Corporation
$372
E.R. Squibb & Sons, L.L.C.
$283
AstraZeneca Pharmaceuticals LP
$281
Genentech USA, Inc.
$217
Lilly USA, LLC
$181
Astellas Pharma US Inc
$119
AbbVie, Inc.
$108
Incyte Corporation
$99
Takeda Pharmaceuticals U.S.A., Inc.
$98
Celgene Corporation
$94
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
TESARO, Inc.
$91
GlaxoSmithKline, LLC.
$88
Gilead Sciences, Inc.
$83
Alexion Pharmaceuticals, Inc.
$77
Kite Pharma, Inc.
$59
Ipsen Biopharmaceuticals, Inc
$56
Bayer HealthCare Pharmaceuticals Inc.
$47
Janssen Pharmaceuticals, Inc
$46
Grifols USA, LLC
$44
Aurobindo Pharma USA, Inc.
$41
GENZYME CORPORATION
$39
Eisai Inc.
$38
EISAI INC.
$38
Taiho Oncology, Inc.
$38
ABBVIE INC.
$35
Verastem, Inc.
$34
Advanced Accelerator Applications
$34
Puma Biotechnology, Inc.
$30
Rigel Pharmaceuticals, Inc.
$30
Dova Pharmaceuticals
$30
Seattle Genetics, Inc.
$30
Pharmacyclics LLC, An AbbVie Company
$28
JAZZ PHARMACEUTICALS INC.
$23
Coherus Biosciences Inc.
$22
MEDIVATION FIELD SOLUTIONS LLC
$19
Daiichi Sankyo Inc.
$18
INSYS Therapeutics Inc
$16
Agios Pharmaceuticals, Inc.
$16
Seagen Inc.
$15
Spectrum Pharmaceuticals Inc.
$13
Otsuka America Pharmaceutical, Inc.
$12
TOLMAR Pharmaceuticals, Inc.
$11
Top 3 companies account for 35.2% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Avastin · BOSULIF · CALQUENCE · CHANTIX · CYRAMZA · Copiktra · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · ERLEADA · Erleada · FASLODEX · Folotyn · GAZYVA · GILOTRIF · Gamunex-C · Halaven · IBRANCE · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nplate · OPDIVO · PIQRAY · PROMACTA · Pomalyst · Prolia · REBLOZYL · Revlimid · SANDOSTATIN · SANDOSTATIN LAR · SOLIRIS · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · Tarceva · Tavalisse · ULTOMIRIS · Udenyca · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XTANDI · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
24
Per 100K population
6.9
County median income
$69,027
Nearest hospital
ST LUCIE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Swanson is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Swanson experienced with injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram?
Based on Medicare claims data, Dr. Swanson performed 48,000 injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Swanson receive payments from pharmaceutical companies?
Yes. Dr. Swanson received a total of $5,445 from 47 companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Swanson's costs compare to other hematology & oncologys in Port St Lucie?
Dr. Swanson's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Swanson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Port St Lucie
Browse hematology & oncologys in Port St Lucie ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology